HR 1829
Pharmacy Benefit Manager Accountability Study Act of 2021
Take action
Record your position on this measure.
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed House
- Passed Senate
- To President
- Became Law
Bill overview
This bill directs the Government Accountability Office (GAO) to conduct a comprehensive study of pharmacy benefit managers (PBMs) and their impact on prescription drug costs. The study will examine how PBMs operate within the pharmaceutical supply chain, including their use of rebates, fees, and prior authorization practices. Based on the findings, the GAO will recommend specific legislative changes to lower drug prices, increase competition among PBMs, and improve transparency in the system.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Cosponsors
Bill Posey
Cynthia Axne
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.